Sign In
Buy CLB
$11.64
-0.130 (-1.10%)
At Close: Jun 23, 2026
RBC Capital Thinks Core Laboratories' Stock is Going to Recover
02:42am, Monday, 06'th Apr 2020
In a report issued on April 3, Kurt Hallead from RBC Capital maintained a Buy rating on Core Laboratories (CLB), with a price target of $13.00. The
Kopion Asset Management, LLC Buys Pros Holdings Inc, Hexcel Corp, BorgWarner Inc, Sells Ansys ...
12:00am, Monday, 06'th Apr 2020Core Laboratories N.V. (NYSE:CLB) Earns Among The Best Returns In Its Industry
04:17pm, Friday, 03'rd Apr 2020
Today we'll evaluate Core Laboratories N.V. (NYSE:CLB) to determine whether it could have potential as an investment...
First Republic Investment Management Inc. Lowers Position in Core Laboratories (NYSE:CLB)
10:44am, Friday, 03'rd Apr 2020
First Republic Investment Management Inc. cut its stake in Core Laboratories (NYSE:CLB) by 31.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchan
Bank of America Corp DE Cuts Holdings in Core Laboratories (NYSE:CLB)
09:08am, Friday, 03'rd Apr 2020
Bank of America Corp DE trimmed its holdings in shares of Core Laboratories (NYSE:CLB) by 5.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchang
Core Laboratories (NYSE:CLB) Lowered to Strong Sell at ValuEngine
07:40am, Thursday, 02'nd Apr 2020
Core Laboratories (NYSE:CLB) was downgraded by investment analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a note issued to investors on Thursday, ValuEngine reports. O
Amundi Pioneer Asset Management Inc. Purchases 3,880 Shares of Core Laboratories (NYSE:CLB)
08:58am, Tuesday, 31'st Mar 2020
Amundi Pioneer Asset Management Inc. lifted its position in Core Laboratories (NYSE:CLB) by 155.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund own
Core Laboratories (NYSE:CLB) Position Increased by Credit Suisse AG
12:36pm, Saturday, 28'th Mar 2020
Credit Suisse AG raised its holdings in shares of Core Laboratories (NYSE:CLB) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi
Core Lab Reschedules Time And Location Of Its 2020 Annual Shareholder Meeting While Maintaining Meeting Date Of May 20, 2020
08:15pm, Friday, 27'th Mar 2020
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA"), (the "Company" or "Core Lab") announces that on March 20, 2020, it filed its definitive proxy on form DEF-14A with the U.S. Se
Baird Financial Group Inc. Has $9.28 Million Stock Holdings in Core Laboratories (NYSE:CLB)
09:56am, Friday, 27'th Mar 2020
Baird Financial Group Inc. decreased its holdings in shares of Core Laboratories (NYSE:CLB) by 42.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commis
Core Lab Reschedules Time And Location Of Its —…—… Annual Shareholder Meeting While ...
12:00am, Friday, 27'th Mar 2020Core Laboratories' First Quarter 2020 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On April 23, 2020
08:05pm, Thursday, 26'th Mar 2020
Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2020 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 23, 2020.
Core Laboratories' First Quarter —…—… Webcast At 7:'… A.M. CDT / —:'… P.M. ...
12:00am, Thursday, 26'th Mar 2020Prudential Financial Inc. Raises Position in Core Laboratories (NYSE:CLB)
08:26am, Tuesday, 24'th Mar 2020
Prudential Financial Inc. raised its holdings in shares of Core Laboratories (NYSE:CLB) by 9.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission
Raymond James & Associates Has $3.85 Million Stake in Core Laboratories (NYSE:CLB)
09:44am, Monday, 23'rd Mar 2020
Raymond James & Associates decreased its stake in shares of Core Laboratories (NYSE:CLB) by 16.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 102,212 shares of th
